Cathay Biotech's net profit shrinks 28% in H1 2023

Summary: On 7 Aug., Cathay Biotech launched its semi-annual report for H1 2023 with net profit down by 28.12%, and it was putting off startup of the 500,000 t/a bio-based pentamethylene diamine (PDA) and 900,000 t/a bio-based polyamide (PA) project.O...

Bio-based Material Quarterly Newsletter Q3 2023

www.cnchemicals.com